In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 2167-2171

  May, Addison K ^a,b   Sawyer, Robert G ^a   Gleason, Thomas ^a   Whitworth, Anne ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HEMOLYSIN; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HEMOLYSIS; IMMUNE RESPONSE; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029995425     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.2167-2171.1996     Document Type: Article

References (40)

1. Alexander, H. R., G. M. Doherty, C. M. Buresh, D. J. Venzon, and J. A. Norton. 1991. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029-1032.
2. Bagby, G. J., K. J. Plessala, L. A. Wilson, J. J. Thompson, and S. Nelson. 1991. Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J. Infect. Dis. 163:83-88.
3. Bhakdi, S., N. Mackman, J. Nicaud, and I. B. Holland. 1986. Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect. Immun. 52:63-69.
4. Bhakdi, S., M. Muhly, S. Korom, and G. Schmidt. 1990. Effects of Escherichia coli hemolysin on human monocytes, cytocidal action and stimulation of interleukin-1 release. J. Clin. Invest. 85:1746-1753.
5. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes. Infect. Immun. 58:1951-1958.
6. Boehm, D. F., R. A. Welch, and I. S. Snyder. 1990. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect. Immun. 58:1959-1964.
7. Cavalieri, S. J., G. A. Bohach, and I. S. Snyder. 1984. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity. Microbiol. Rev. 48:326-343.
8. Cooke, E. M. 1968. Properties of strains of Escherichia coli isolated from faeces of patients with ulcerative colitis, patients with acute diarrhea and normal persons. J. Pathol. Bacteriol. 95:101-113.
9. Cooke, E. M., and S. P. Ewins. 1975. Properties of strains of Escherichia coli isolated from a variety of sources. J. Med. Microbiol. 8:107-111.
10. Dinarello, C. A. 1991. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163:1177-1184.
11. Eberspacher, B., H. Ferdinand, and S. Bhakdi. 1989. Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin. Infect. Immun. 57:983-988.
12. Emody, L., I. Ketyi, B. Kuch, and S. Pacsa. 1979. Antitoxic immunity against the so-called lung toxin produced by Escherichia coli. Acta Microbiol. Acad. Sci. Hung. 26:233-239.
13. Evans, D. J., D. G. Evans, C. Hohne, M. A. Noble, E. V. Haldane, H. Lior, and L. S. Young. 1981. Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections. J. Clin. Microbiol. 13:171-178.
14. Felmlee, T., S. Pellet, and R. Welch. 1985. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J. Bacteriol. 163:94-105.
15. Gadeberg, O. V., I. Ørskov, and K. M. Rhodes. 1983. Cytotoxic effect of an alpha-hemolytic Escherichia coli strain on human blood monocytes and granulocytes in vitro. Infect. Immun. 41:358-364.
16. Grimminger, F., U. Sibelius, S. Bhakdi, N. Suttorp, and W. Seeger. 1991. Escherichia coli hemolysin is a potent inductor of phosphoinisitide hydrolysis and related metabolic responses in human neutrophils. J. Clin. Invest. 88: 1531-1539.
17. Ketyi, I., L. Emody, T. Kantrohr, A. Vertenyi, S. Pacsa, T. A. Avdeeva, N. V. Safonova, and N. K. Golutova. 1978. Mouse lung oedema caused by a toxic substance of Escherichia coli strains. Acta Microbiol. Acad. Sci. Hung. 25:307-317.
18. Konig, B., W. Konig, J. Scheffer, J. Hacker, and W. Goebel. 1986. Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect. Immun. 54:886-892.
19. Konig, B., W. Schonfeld, J. Scheffer, and W. Konig. 1990. Signal transduction in human platelets and inflammatory mediator release induced by genetically cloned hemolysin-positive and -negative Escherichia coli strains. Infect. Immun. 58:1591-1599.
20. Koronakis, V., M. Cross, B. Senior, E. Koronakis, and C. Hughes. 1987. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha hemolysin of Escherichia coli. J. Bacteriol. 169:1509-1515.
21. Ludwig, A., A. Schmid, R. Benz, and W. Goebel. 1991. Mutations affecting pore formation by hemolysin from Escherichia coli. Mol. Gen. Genet. 226:198-208.
22. Mackman, N., and I. B. Holland. 1984. Functional characterization of a cloned haemolysin determinant from E. coli of human origin, encoding information for the secretion of a 107K polypeptide. Mol. Gen. Genet. 320:123-134.
23. May, A. K., T. L. Pruett, R. B. Adams, R. G. Sawyer, and M. Spengler. 1991. Abstr. 34. In Program and abstracts of the 11th Annual Meeting, Surgical Infection Society.
24. Minshew, B. H., J. Jorgensen, G. W. Counts, and S. Falkow. 1978. Association of hemolysin production, hemagglutination of human erythrocytes, and virulence for chicken embryos of extraintestinal Escherichia coli isolates. Infect. Immun. 20:50-54.
25. Minshew, B. H., J. Jorgensen, M. Swanstrum, G. A. Grootes-Reuvecamp, and S. Falkow. 1978. Some characteristics of Escherichia coli strains from extraintestinal infections in humans. J. Infect. Dis. 137:648-654.
26. O'Hanley, P., G. Lalonde, and G. Ji. 1991. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect. Immun. 59:1153-1161.
27. Orskov, F. 1978. Virulence factors of the bacterial cell surface. J. Infect. Dis. 137:630-633.
28. Porat, R., B. D. Clark, S. M. Wolff, and C. A. Dinarello. 1991. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430-432.
29. Sanchez-Cantu, L., H. N. Rhode, and N. V. Christou. 1989. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch. Surg. 124:1432-1435.
30. Sanchez-Cantu, L., H. N. Rhode, T. J. Yun, and N. V. Christou. 1991. Tumor necrosis factor alone docs not explain the lethal effect of lipopolysaccharide. Arch. Surg. 126:231-235.
31. Seeger, W., R. Obernitz, M. Thomas, D. Walmrath, N. Suttorn, I. B. Holland, F. Grimminger, B. Eberspacher, F. Hugo, and S. Bhakdi. 1991. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs. Am. Rev. Respir. Dis. 143:797-805.
32. Sparling, P. F. 1983. Bacterial virulence and pathogenesis: an overview. Rev. Infect. Dis. 5:S637-S646.
33. Strathdee, C. A., and R. Y. Lo. 1987. Extensive homology between the leukotoxin of Pasterella haemolysin A1 and the alpha-hemolysin of Escherichia coli. Infect. Immun. 55:3233-3236.
34. Suttorp, N., B. Floer, H. Schnittler, W. Seeger, and S. Bhakdi. 1990. Effects of Escherichia coli hemolysin on endothelial cell function. Infect. Immun. 58:3796-3801.
35. Svanborg Eden, C., and P. de Man. 1987. Bacterial virulence in urinary tract infection. Infect. Dis. Clin. N. Am. 1:731-750.
36. Van den Bosch, J. F., P. Postma, J. De Graaff, and D. M. MacLaren. 1981. Hemolysis by urinary Escherichia coli and virulence in mice. J. Med. Microbiol. 14:321-333.
37. Waalwijk, C., D. M. MacLaren, and J. De Graaff. 1983. In vivo function of hemolysin in the nephropathogenicity of Escherichia coli. Infect. Immun. 42:245-249.
38. Welch, R. A., E. P. Dellinger, B. Minshew, and S. Falkow. 1981. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature (London) 294:665-667.
39. Welch, R. A., and S. Falkow. 1984. Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence. Infect. Immun. 43:156-160.
40. Welch, R. A., R. Hull, and S. Falkow. 1983. Molecular cloning and physical characterization of a chromosomal hemolysin from Escherichia coli. Infect. Immun. 42:178-186.